Obsessive-compulsive disorder

New England Journal of Medicine

Volumn 371, Issue 7, 2014, Pages 646-653

  Grant, Jon E ^a  

^a UNIVERSITY OF CHICAGO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CLOMIPRAMINE; SEROTONIN UPTAKE INHIBITOR; TRICYCLIC ANTIDEPRESSANT AGENT;

ARTICLE; BRAIN DEPTH STIMULATION; CLINICAL FEATURE; COGNITIVE THERAPY; COMPARATIVE STUDY; DIAGNOSTIC PROCEDURE; DRUG EFFICACY; EVIDENCE BASED MEDICINE; EXPOSURE AND RESPONSE PREVENTION THERAPY; GENETIC PREDISPOSITION; HUMAN; MONOTHERAPY; NEUROANATOMY; OBSESSIVE COMPULSIVE DISORDER; ONSET AGE; PATHOLOGICAL ANATOMY; PATIENT DECISION MAKING; PATIENT EDUCATION; PRACTICE GUIDELINE; PRIORITY JOURNAL; PSYCHOPHARMACOTHERAPY; PSYCHOTHERAPY; SEX RATIO; TREATMENT DURATION; TREATMENT INDICATION; TREATMENT OUTCOME; UNCERTAINTY; BEHAVIOR THERAPY; DIAGNOSTIC ERROR; DIFFERENTIAL DIAGNOSIS; MALE; MULTIMODALITY CANCER THERAPY; REVIEW; YOUNG ADULT;

ANTIDEPRESSIVE AGENTS, TRICYCLIC; COGNITIVE THERAPY; COMBINED MODALITY THERAPY; DEEP BRAIN STIMULATION; DIAGNOSIS, DIFFERENTIAL; DIAGNOSTIC ERRORS; HUMANS; IMPLOSIVE THERAPY; MALE; OBSESSIVE-COMPULSIVE DISORDER; PRACTICE GUIDELINES AS TOPIC; SEROTONIN UPTAKE INHIBITORS; YOUNG ADULT;

EID: 84906085466     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJMcp1402176     Document Type: Article

References (50)

1. Ruscio AM, Stein DJ, Chiu WT, Kessler RC. The epidemiology of obsessive-compulsive disorder in the National Comorbidity Survey Replication. Mol Psychiatry 2010;15:53-63.
2. Karno M, Golding JM, Sorenson SB, Burnam MA. The epidemiology of obsessive-compulsive disorder in five US communities. Arch Gen Psychiatry 1988;45:1094-9. (Pubitemid 19005463)
3. Ayuso-Mateos J. Global burden of obsessive-compulsive disorder in the year 2000. Geneva: World Health Organization, 2006.
4. American Psychiatric Association. Diagnostic and statistical manual of mental disorders. 5th ed. Washington, DC: American Psychiatric Association, 2013.
5. Greenberg D, Witztum E. The influence of cultural factors on obsessive compulsive disorder: religious symptoms in a religious society. Isr J Psychiatry Relat Sci 1994;31:211-20.
6. Fontenelle LF, Mendlowicz MV, Marques C, Versiani M. Trans-cultural aspects of obsessive-compulsive disorder: a description of a Brazilian sample and a systematic review of international clinical studies. J Psychiatr Res 2004;38:403-11. (Pubitemid 38760008)
7. Geller DA, Biederman J, Faraone S, et al. Developmental aspects of obsessive compulsive disorder: findings in children, adolescents, and adults. J Nerv Ment Dis 2001;189:471-7. (Pubitemid 32730210)
8. Geller DA. Obsessive-compulsive and spectrum disorders in children and adolescents. Psychiatr Clin North Am 2006;29:353-70.
9. Narayanaswamy JC, Viswanath B, Veshnal Cherian A, Bada Math S, Kandavel T, Janardhan Reddy YC. Impact of age of onset of illness on clinical phenotype in OCD. Psychiatry Res 2012;200:554-9.
10. Grant JE, Mancebo MC, Pinto A, Williams KA, Eisen JL, Rasmussen SA. Late-onset obsessive compulsive disorder: clinical characteristics and psychiatric comorbidity. Psychiatry Res 2007;152:21-7. (Pubitemid 47033907)
11. Kalra SK, Swedo SE. Children with obsessive-compulsive disorder: are they just "little adults"? J Clin Invest 2009;119:737-46.
12. van Grootheest DS, Cath DC, Beekman AT, Boomsma DI. Twin studies on obsessive-compulsive disorder: a review. Twin Res Hum Genet 2005;8:450-8. (Pubitemid 41499486)
13. Stewart SE, Yu D, Scharf JM, et al. Genome-wide association study of obsessive-compulsive disorder. Mol Psychiatry 2013;18:788-98.
14. Stewart SE, Mayerfeld C, Arnold PD, et al. Meta-analysis of association between obsessive-compulsive disorder and the 3′ region of neuronal glutamate transporter gene SLC1A1. Am J Med Genet B Neuropsychiatr Genet 2013;162B:367-79.
15. Saxena S, Rauch SL. Functional neuroimaging and the neuroanatomy of obsessive-compulsive disorder. Psychiatr Clin North Am 2000;23:563-86. (Pubitemid 30666507)
16. Baxter LR Jr, Phelps ME, Mazziotta JC, Guze BH, Schwartz JM, Selin CE. Local cerebral glucose metabolic rates in obsessive-compulsive disorder: a comparison with rates in unipolar depression and in normal controls. Arch Gen Psychiatry 1987;44:211-8. (Pubitemid 17023134)
17. Milad MR, Rauch SL. Obsessive-compulsive disorder: beyond segregated corticostriatal pathways. Trends Cogn Sci 2012;16:43-51.
18. Graybiel AM, Rauch SL. Toward a neurobiology of obsessive-compulsive disorder. Neuron 2000;28:343-7.
19. Piras F, Piras F, Caltagirone C, Spalletta G. Brain circuitries of obsessive compulsive disorder: a systematic review and meta-analysis of diffusion tensor imaging studies. Neurosci Biobehav Rev 2013;37:2856-77.
20. Menzies L, Achard S, Chamberlain SR, et al. Neurocognitive endophenotypes of obsessive-compulsive disorder. Brain 2007;130:3223-36. (Pubitemid 350209066)
21. Chamberlain SR, Menzies L, Hampshire A, et al. Orbitofrontal dysfunction in patients with obsessive-compulsive disorder and their unaffected relatives. Science 2008;321:421-2. (Pubitemid 352029981)
22. Skoog G, Skoog I. A 40-year follow-up of patients with obsessive-compulsive disorder. Arch Gen Psychiatry 1999;56:121-7. (Pubitemid 29081385)
23. Mancebo MC, Eisen JL, Pinto A, Greenberg BD, Dyck IR, Rasmussen SA. The Brown Longitudinal Obsessive Compulsive Study: treatments received and patient impressions of improvement. J Clin Psychiatry 2006;67:1713-20. (Pubitemid 44955151)
24. Reddy YC, D'Souza SM, Shetti C, et al. An 11- to 13-year follow-up of 75 subjects with obsessive-compulsive disorder. J Clin Psychiatry 2005;66:744-9. (Pubitemid 40942421)
25. Blanco C, Olfson M, Stein DJ, Simpson HB, Gameroff MJ, Narrow WH. Treatment of obsessive-compulsive disorder by U.S. psychiatrists. J Clin Psychiatry 2006;67:946-51. (Pubitemid 44049093)
26. Jacob ML, Larson MJ, Storch EA. Insight in adults with obsessive-compulsive disorder. Compr Psychiatry 2014;55:896-903.
27. Ginsburg GS, Kingery JN, Drake KL, Grados MA. Predictors of treatment response in pediatric obsessive-compulsive disorder. J Am Acad Child Adolesc Psychiatry 2008;47:868-78.
28. Foa EB. Cognitive behavioral therapy of obsessive-compulsive disorder. Dialogues Clin Neurosci 2010;12:199-207.
29. Simpson HB, Maher MJ, Wang Y, Bao Y, Foa EB, Franklin M. Patient adherence predicts outcome from cognitive behavioral therapy in obsessive-compulsive disorder. J Consult Clin Psychol 2011;79:247-52.
30. Rosa-Alcázar AI, Sánchez-Meca J, Gómez-Conesa A, Marín-Martínez F. Psychological treatment of obsessive-compulsive disorder: a meta-analysis. Clin Psychol Rev 2008;28:1310-25.
31. Ponniah K, Magiati I, Hollon SD. An update on the efficacy of psychological therapies in the treatment of obsessive-compulsive disorder in adults. J Obsessive Compuls Relat Disord 2013;2:207-18.
32. Lovell K, Cox D, Haddock G, et al. Telephone administered cognitive behaviour therapy for treatment of obsessive compulsive disorder: randomised controlled non-inferiority trial. BMJ 2006;333:883.
33. Greist JH, Marks IM, Baer L, et al. Behavior therapy for obsessive-compulsive disorder guided by a computer or by a clinician compared with relaxation as a control. J Clin Psychiatry 2002;63:138-45. (Pubitemid 34173851)
34. Andersson E, Enander J, Andrén P, et al. Internet-based cognitive behaviour therapy for obsessive-compulsive disorder: a randomized controlled trial. Psychol Med 2012;42:2193-203.
35. van Oppen P, van Balkom AJ, Smit JH, Schuurmans J, van Dyck R, Emmelkamp PM. Does the therapy manual or the therapist matter most in treatment of obsessive-compulsive disorder? A randomized controlled trial of exposure with response or ritual prevention in 118 patients. J Clin Psychiatry 2010;71:1158-67.
36. Rachman S, de Silva P. Abnormal and normal obsessions. Behav Res Ther 1978;16:233-48. (Pubitemid 9044753)
37. Greist JH, Bandelow B, Hollander E, et al. WCA recommendations for the long-term treatment of obsessive-compulsive disorder in adults. CNS Spectr 2003;8:Suppl 1:7-16. (Pubitemid 38419777)
38. Abramowitz JS. The psychological treatment of obsessive-compulsive disorder. Can J Psychiatry 2006;51:407-16. (Pubitemid 44065742)
39. Bandelow B, Zohar J, Hollander E, et al. World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for the pharmacological treatment of anxiety, obsessive-compulsive and post-traumatic stress disorders - first revision. World J Biol Psychiatry 2008;9:248-312.
40. Soomro GM, Altman D, Rajagopal S, Oakley-Browne M. Selective serotonin reuptake inhibitors (SSRIs) versus placebo for obsessive compulsive disorder (OCD). Cochrane Database Syst Rev 2008;1:CD001765.
41. Ackerman DL, Greenland S. Multivariate meta-analysis of controlled drug studies for obsessive-compulsive disorder. J Clin Psychopharmacol 2002;22:309-17. (Pubitemid 34546847)
42. American Psychiatric Association. Practice guidelines for the treatment of patients with obsessive-compulsive disorder. Am J Psychiatry 2007;164:Suppl: 1-56.
43. Reddy YC, Alur AM, Manjunath S, Kandavel T, Math SB. Long-term follow-up study of patients with serotonin reuptake inhibitor-nonresponsive obsessive-compulsive disorder. J Clin Psychopharmacol 2010;30:267-72.
44. Ravizza L, Maina G, Bogetto F, Albert U, Barzega G, Bellino S. Long term treatment of obsessive-compulsive disorder. CNS Drugs 1998;10:247-55. (Pubitemid 28516748)
45. Romanelli RJ, Wu FM, Gamba R, Mojtabai R, Segal JB. Behavioral therapy and serotonin reuptake inhibitor pharmacotherapy in the treatment of obsessive-compulsive disorder: a systematic review and meta-analysis of head-to-head randomized controlled trials. Depress Anxiety 2014 January 3 (Epub ahead of print).
46. Bloch MH, Landeros-Weisenberger A, Kelmendi B, Coric V, Bracken MB, Leckman JF. A systematic review: antipsychotic augmentation with treatment refractory obsessive-compulsive disorder. Mol Psychiatry 2006;11:622-32. (Pubitemid 43989810)
47. Simpson HB, Foa EB, Liebowitz MR, et al. Cognitive-behavioral therapy vs risperidone for augmenting serotonin reuptake inhibitors in obsessive-compulsive disorder: a randomized clinical trial. JAMA Psychiatry 2013;70:1190-9.
48. Kordon A, Kahl KG, Broocks A, Voderholzer U, Rasche-Räuchle H, Hohagen F. Clinical outcome in patients with obsessive-compulsive disorder after discontinuation of SRI treatment: results from a two-year follow-up. Eur Arch Psychiatry Clin Neurosci 2005;255:48-50. (Pubitemid 40558105)
49. Goodman WK, Alterman RL. Deep brain stimulation for intractable psychiatric disorders. Annu Rev Med 2012;63:511-24.
50. Obsessive-compulsive disorder: core interventions in the treatment of obsessive-compulsive disorder and body dysmorphic disorder. London: National Institute for Health and Clinical Excellence, November 2005 (http://www.nice. org.uk/nicemedia/pdf/cg031niceguideline.pdf).